01/22/2026
Smokeless To***co & Oral Cancer: A Preventable Global Crisis
Smokeless to***co (ST) is used by more than 360 million people worldwide and is a leading contributor to oral cancer, particularly in low- and middle-income countries. While cigarette smoking has declined in many regions, ST use is rising—especially in South and Southeast Asia.
📊 Key facts:
- ST is classified as a Group 1 carcinogen
- Nearly 390,000 new oral cancer cases were reported globally in 2022
- About 30% of oral cancers are linked to smokeless to***co and/or areca nut use
- Use is increasing among women and youth in several regions
The good news: Both ST use and oral cancer are preventable.
Clinical interventions—including asking about ST use, conducting oral exams, and offering evidence-based cessation support—can make a meaningful difference.
Health professionals play a critical role in early detection, prevention, and reducing global health disparities.
👉 Read the full article on ATLMed.org/category/atlmed-news/
***co